Our results in the blood cohort showed that the promoter hypomethylation of CYP24A1 was also present in the leukocytes of CRC patients compared to healthy controls, which was consistent with findings in the GEO tissue cohort. This evidence concerns the gene CYP24A1 and colorectal carcinoma.